{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:05:16Z","timestamp":1789693516186,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,31]],"date-time":"2027-07-31T00:00:00Z","timestamp":1816992000000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005348","name":"American Association for Thoracic Surgery","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006751","name":"US Department of the Army","doi-asserted-by":"publisher","award":["HT9425-25-1-0696"],"award-info":[{"award-number":["HT9425-25-1-0696"]}],"id":[{"id":"10.13039\/100006751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtcvs.2026.03.594","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T07:46:54Z","timestamp":1774338414000},"page":"467-475.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phase 1\/1b study of direct intratumoral injection of pleural mesothelioma of immunostimulant prior to surgical resection"],"prefix":"10.1016","volume":"172","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3645-2917","authenticated-orcid":false,"given":"Andrea S.","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal","family":"Dolasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailey","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Yankelevitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Tsankov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Marron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2026.03.594_bib1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJM196503182721104","article-title":"Relation between exposure to asbestos and mesothelioma","volume":"272","author":"Selikoff","year":"1965","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jtcvs.2026.03.594_bib2","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.jtho.2023.08.005","article-title":"The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: updated modeling of prognostic factors in pleural mesothelioma","volume":"18","author":"Wolf","year":"2023","journal-title":"J Thorac Oncol"},{"issue":"12","key":"10.1016\/j.jtcvs.2026.03.594_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145039","article-title":"Determinants of survival in malignant pleural mesothelioma: a surveillance, epidemiology, and end results (SEER) study of 14,228 patients","volume":"10","author":"Taioli","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.03.594_bib4","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jtcvs.2017.11.060","article-title":"Mesothelioma: live to fight another day","volume":"155","author":"Wolf","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.594_bib5","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1186\/s12885-018-5064-4","article-title":"Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"18","author":"Schwartz","year":"2018","journal-title":"BMC Cancer"},{"issue":"10272","key":"10.1016\/j.jtcvs.2026.03.594_bib6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.03.594_bib7","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","article-title":"Expansion and activation of CD103(+) dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition","volume":"44","author":"Salmon","year":"2016","journal-title":"Immunity"},{"issue":"48","key":"10.1016\/j.jtcvs.2026.03.594_bib8","doi-asserted-by":"crossref","first-page":"E7759","DOI":"10.1073\/pnas.1609376113","article-title":"Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma","volume":"113","author":"Spranger","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"10.1016\/j.jtcvs.2026.03.594_bib9","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1158\/1078-0432.CCR-17-1866","article-title":"Therapeutic immune modulation against solid cancers with intratumoral poly-ICLC: a pilot trial","volume":"24","author":"Kyi","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"226","key":"10.1016\/j.jtcvs.2026.03.594_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008095","article-title":"Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy","volume":"6","author":"Zamarin","year":"2014","journal-title":"Sci Transl Med"},{"issue":"25","key":"10.1016\/j.jtcvs.2026.03.594_bib11","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","article-title":"Talimogene laherparepvec improves durable response rate in patients with advanced melanoma","volume":"33","author":"Andtbacka","year":"2015","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jtcvs.2026.03.594_bib12","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1084\/jem.20111171","article-title":"Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans","volume":"208","author":"Caskey","year":"2011","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.03.594_bib13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/14760584.2015.966085","article-title":"Vaccine adjuvant uses of poly-IC and derivatives","volume":"14","author":"Martins","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"10.1016\/j.jtcvs.2026.03.594_bib14","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1158\/2326-6066.CIR-14-0024","article-title":"Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial","volume":"2","author":"Salazar","year":"2014","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.594_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13046-021-02017-2","article-title":"A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy","volume":"40","author":"Verhezen","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jtcvs.2026.03.594_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/JHC.S136652","article-title":"A phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect","volume":"4","author":"de la Torre","year":"2017","journal-title":"J Hepatocell Carcinoma"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.03.594_bib17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1158\/1078-0432.CCR-14-1790","article-title":"Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC","volume":"21","author":"Okada","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"Suppl 1","key":"10.1016\/j.jtcvs.2026.03.594_bib18","first-page":"1043","article-title":"1043 Intratumoral mRNA IL-12 can induce a dose dependent immunostimulatory effect within tumor microenvironment in patients with advanced solid tumors","volume":"11","author":"Abadier","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"8","key":"10.1016\/j.jtcvs.2026.03.594_bib19","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jtho.2024.01.018","article-title":"The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: expanded database to inform revisions in the ninth edition of the TNM classification of pleural mesothelioma","volume":"19","author":"Wolf","year":"2024","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.03.594_bib20","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.athoracsur.2010.04.110","article-title":"Characteristics of malignant pleural mesothelioma in women","volume":"90","author":"Wolf","year":"2010","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.594_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jso.27243","article-title":"Malignant pleural mesothelioma characteristics and outcomes: a SEER-Medicare analysis","volume":"128","author":"Taioli","year":"2023","journal-title":"J Surg Oncol"},{"issue":"11","key":"10.1016\/j.jtcvs.2026.03.594_bib22","doi-asserted-by":"crossref","first-page":"12208","DOI":"10.1002\/cam4.5915","article-title":"Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: a review of the National Cancer Database","volume":"12","author":"Bou-Samra","year":"2023","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.594_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S2213-2600(24)00119-X","article-title":"Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial","volume":"12","author":"Lim","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.594_bib24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MPH.0000000000000047","article-title":"Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors","volume":"36","author":"Hartman","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtcvs.2026.03.594_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.lungcan.2017.07.010","article-title":"Pathological complete response in malignant pleural mesothelioma patients following induction chemotherapy: predictive factors and outcomes","volume":"111","author":"Lau","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtcvs.2026.03.594_bib26","article-title":"Should treatment of mesothelioma include surgery? MARS2 fails to land","author":"Gulati","year":"2024","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.594_bib27","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jtcvs.2024.12.006","article-title":"Going to MARS may shorten our patient\u2019s survival","volume":"169","author":"Ripley","year":"2025","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"7","key":"10.1016\/j.jtcvs.2026.03.594_bib28","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/jso.25260","article-title":"Short-term outcomes of pleurectomy decortication and extrapleural pneumonectomy in mesothelioma","volume":"118","author":"van Gerwen","year":"2018","journal-title":"J Surg Oncol"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.594_bib29","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02114-2023","article-title":"A randomised phase II study of extended pleurectomy\/decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC 1205","volume":"63","author":"Raskin","year":"2024","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.594_bib30","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1016\/j.jtcvs.2017.12.131","article-title":"Macroscopic complete resection is not associated with improved survival in patients with malignant pleural mesothelioma","volume":"155","author":"Batirel","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2026.03.594_bib31","author":"Gulati"},{"issue":"10419","key":"10.1016\/j.jtcvs.2026.03.594_bib32","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0140-6736(23)01613-6","article-title":"Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial","volume":"402","author":"Chu","year":"2023","journal-title":"Lancet"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522326007920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522326007920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:42:30Z","timestamp":1789692150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522326007920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0022522326007920"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2026.03.594","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 1\/1b study of direct intratumoral injection of pleural mesothelioma of immunostimulant prior to surgical resection","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2026.03.594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}